Voclosporin

From Wikipedia, the free encyclopedia
Voclosporin
Identifiers
PubChem 6918486
ChemSpider 5293683
Jmol-3D images {{#if:O=C1N(C)[C@H](C(=O)N[C@H](C(=O)N(C)CC(=O)N(C)[C@H](C(=O)N[C@H](C(=O)N(C)[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@H]1C(C)C)CC(C)C)CC(C)C)C)C)C)CC(C)C)C(C)C)CC(C)C)CC)[C@H](O)[C@H](C)C\C=C\C=C|Image 1
Properties
Molecular formula C63H111N11O12
Molar mass 1,214.62 g mol−1
Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa)
Infobox references

Voclosporin is an experimental immunosuppressant drug being developed by Isotechnika and Lux Biosciences.[1] It is being studied for use in solid organ transplantation and autoimmune diseases such as psoriasis. It is an analog of ciclosporin that has enhanced action against calcineurin and greater metabolic stability.[2]

References

  1. "Voclosporin". Psoriasis Cure Now. Retrieved October 19, 2012. 
  2. "What is voclosporin?". Isotechnika. Retrieved October 19, 2012. 

External links


This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.